Tuesday 2 April 2024

BioLargo achieved 108% year-over-year revenue growth in 2023

Westminster, CA – April 2, 2024 – BioLargo, Inc. (OTCQB:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its Annual Report, filed April 1, 2024, showed the company’s annual revenues increased by 108% year-over-year compared to 2022 (www.biolargo.com/sec-filings).

BioLargo will hold an investor webcast on Tuesday, April 2, 2024, at 2:00 pm Pacific / 5:00 pm Eastern, at the following link, open to the public: https://www.webcaster4.com/Webcast/Page/2448/50271   

Dennis P. Calvert, the company’s President and CEO, commented, “Rising odor control product sales continue to push our business forward. We are confident that our PFAS solutions will find additional traction in 2024 and believe they will eventually contribute significantly to our overall growth trajectory. Almost cash-flow positive in the fourth quarter of 2023, we continue to focus our business on leveraging our intellectual property and partnering with great companies to scale up sales and distribution while preserving capital and human resources.”

The following are select highlights from BioLargo’s annual report filed April 1, 2024, and are not a substitute for the details in the 10-K, which can be found here (https://www.biolargo.com/sec-filings). All interested parties are encouraged to review the full report filed with the SEC, including the risk factors at page 9, to get the most complete information about BioLargo and its growing cleantech business.

Financial highlights from the annual report:

  • Revenues for the year ended December 31, 2023, were $12,230,000, a 108% increase over 2022.
  • Revenues in the fourth quarter of 2023 were $4,370,000, a 64% increase as compared with the third quarter of 2023 (quarter-over-quarter), and a 108% increase as compared with the fourth quarter of 2022.
  • Cash flow from operations for the year was negative $2,365,000.
  • The company’s net loss for the year ended December 31, 2023, was reduced by 9% as compared with the prior year, from $5,132,000 to $4,648,000. More than 60% of the company’s net loss was due to non-cash expenses, including $2,124,000 of stock option compensation expense, and $384,000 of services paid by the issuance of our common stock.
  • 21% of the company’s total operating expenses in 2023 were from research and development, up from 16% in 2022, as we built out a facility to manufacture and test our first batteries.
  • Total stockholders’ equity more than doubled - from $2,011,000 at December 31, 2022, to $4,202,000 at December 31, 2023.
  • Total assets as of December 31, 2023 were $8,205,000, against total liabilities of $4,003,000.
  • The company ended the year with working capital of $3,652,000.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com. 

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Monday 1 April 2024

BioLargo Year-End 2023 Earnings Results Webcast and Conference Call on Tuesday, April 2, 2024 – 5:00 PM Eastern Time

Westminster, CA – April 1, 2024– BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Tuesday, April 2, 2024, at 2:00 pm Pacific / 5:00 pm Eastern. Open to the public, the webcast will be held to review the company’s financial results for the year ending December 31, 2023, discuss recent milestones, and conduct a question-and-answer session.

To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.


To participate in the live webcast and teleconference:

Webcast Link: https://www.webcaster4.com/Webcast/Page/2448/50271

Teleconference Domestic: 877-545-0523

Teleconference International: 973-528-0016

Participant Access Code: 614240


To watch or listen to a replay of the webcast or teleconference:

Webcast Replay Expiration: Tuesday, July 02, 2024

Teleconference Replay Expiration: Tuesday, April 16, 2024

Teleconference Replay Domestic: 877-481-4010

Teleconference Replay International: 919-882-2331

Replay Passcode: 50271

The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo’s website at www.biolargo.com/investor-relations


About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.   

Contact Information

Dennis P. Calvert 

President and CEO, BioLargo, Inc. 

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.


Monday 25 March 2024

BioLargo to Present at The LD Micro Invitational XIV

 Westminster, CA, March 25, 2024--(Newsfile Corp.) – BioLargo, Inc. (OTCQB:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced today that it will be presenting at the 14th annual LD Micro Invitational investor conference on April 9, 2024, at 2:30 PM ET, at the Sofitel New York hotel. Dennis P. Calvert, President and CEO of BioLargo, will be giving the presentation.

Mr. Calvert’s presentation will focus on the company’s 2023 financial results, in which revenues more than doubled from 2022, as well as the progress of multiple commercial initiatives including consumer pet odor control, the company’s liquid sodium battery energy storage system, and the company’s PFAS water treatment business. 

We invite interested parties to register to watch BioLargo’s presentation virtually here: https://ldinv14.sequireevents.com/ 


About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.  

About LD Micro

LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Whether it is the Index, comprehensive data, or hosting the most significant events annually, LD's sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies. For more information on LD Micro, visit www.ldmicro.com.

Please reach out to the company representative below or Dean Summers (dean@ldmicro.com) to register for the event or schedule a meeting with BioLargo. 

To learn more about Freedom US Markets, visit www.freedomusmkts.com


For further information on BioLargo, Inc.:

Dennis P. Calvert 

President and CEO, BioLargo, Inc. 

888-400-2863

dennis.calvert@biolargo.com

www.biolargo.com 


Friday 22 March 2024

PFAS Regulatory Hearings in the Senate – Our Take

For those unaware, the Senate held a hearing this week regarding regulating per- and polyfluoroalkyl substances (#PFAS) under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA). If this happens, sites badly contaminated by PFAS would be subject to enforcement under CERCLA, meaning those parties responsible for the contamination would have to pay for its cleanup. This proposal is separate from the proposals to regulate PFAS under the Safe Drinking Water Act (which would require drinking water treatment plants to monitor and treat for PFAS) and the Resource Conservation and Recovery Act (which would create rules to treat PFAS-containing substances as hazardous constituents).

At BioLargo, obviously we have strong opinions in this situation (we’re selling PFAS treatment solutions!), but we think most people will agree that regulating PFAS under CERCLA is good thing. Why? Because it will help ensure that these badly contaminated lands get remediated, and protect future generations from these damaging contaminants. It will also hold polluters responsible, and create a budget for sites to get cleaned up (and as a reminder, if a polluter can’t be identified, the “superfund” helps pay for its cleanup). Finally, regulating PFAS under CERCLA is an admission that PFAS is a problem that demands a solution that is  “cradle-to-grave”, meaning you shouldn’t just sequester PFAS in a landfill somewhere.

The Senate meeting this week was held to discuss the potential for creating a carve-out exception under the proposed CERCLA PFAS rules for “passive receivers”, which are sites or facilities that receive PFAS-containing materials incidentally, rather than it being something they generate as part of their business. Examples of passive receivers include wastewater treatment facilities and landfills. The hearing helped illuminate how the federal government is looking at tackling the issue of PFAS-contaminated sites, and how they hope to hold polluters responsible while not causing undue collateral damage.

Some highlights from the hearing:

  • The committee’s main concern was that “passive receivers” of PFAS-containing materials might be on the hook for PFAS cleanup if the chemicals are regulated under CERCLA with no provisions to protect them.
  • Handling of PFAS-laden wastes, and the costs associated with that waste, was a concern to committee members.
  • Members of the committee mentioned that carbon filtration and ion exchange are the ”best available” treatment options – from our perspective, this is basically the government acknowledging that GAC and ion exchange are the only technologies already available (so far) at large-scale to solve the problem, even though they’re in many ways not ideally suited to treat PFAS. These technologies have real downsides: they have “blind spots” of short-chain PFAS species that they struggle to remove, and they generate a lot of solid waste in the process of treatment.  We believe these solutions will fall short in the long run!
  • While the committee was split on the particulars of who should be held responsible for PFAS contamination and how, no one argued that PFAS isn’t dangerous and shouldn’t be treated.

It’s at this point that we have to remind everyone that BioLargo’s PFAS treatment solution, the Aqueous Electrostatic Concentrator (AEC) is an ideal solution to treat PFAS in a post-CERCLA regulations world. Why? Because the AEC is designed from the ground up to concentrate PFAS onto an extremely small surface area – meaning it creates far less PFAS-laden waste than things like ion exchange or carbon filtration.

We stand ready to help industry and passive receivers clean up their water, as well as their waste streams including wastewater and leachate, and help them minimize their CERCLA liability exposure.

As the situation regarding PFAS regulations evolve, we’ll try to keep people updated! I will be presenting next week at the MWEA/AWWA 2024 Join Annual Meeting about these topics, and several other events throughout the summer.

$BLGO #PFAS #BestPFASSolution

- Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, Inc.

www.biolargoequipment.com

Tuesday 20 February 2024

BioLargo adds Larry Dick, prominent water industry veteran, to board of its water equipment subsidiary

Larry Dick
Westminster, CA – February 20, 2024 – BioLargo, Inc. (OTCQB:BLGO), a cleantech developer that creates innovative technologies to solve demanding environmental challenges, announced that Larry Dick, a member of the board of directors of the Municipal Water District of Orange County, California (MWDOC) and former Vice Chairman of the board of the Metropolitan Water District of Southern California (MWDSC), has joined the board of directors of its water equipment subsidiary (BioLargo Equipment Solutions & Technologies; www.bestPFAStreatment.com). Larry brings his relationships and years of experience in water management to help BioLargo commercialize its portfolio of innovative, sustainable water treatment technologies, including its revolutionary technology to treat water contaminated with per- and polyfluoroalkyl substances (PFAS).

Over the past 20 years, Larry has held leadership positions including Vice Chairman at the MWDSC, the largest drinking water agency in the United States. Throughout that time, he also served as President of the Board of Directors of MWDOC and held positions at the Association of California Water Agencies, the Water Advisory Committee of Orange County, and the Urban Water Institute. He is a dedicated public servant committed to delivering safe, sustainable, affordable water to Californians.

In joining the board of BioLargo’s equipment subsidiary, Larry brings long-established business relationships and connections in the water industry as BEST begins to commercialize its innovative water treatment solutions. He aims to help build the company’s reputation and secure new partnerships and opportunities for growth in the Southern California area.

Larry commented, “Improving the quality and access of Americans’ water has been my life’s work for the past two decades. I joined the board of BioLargo’s water equipment and PFAS solutions company because of how clear to me it is that this same mission – improving and safeguarding our water – is a core value for all their team members.” 

About BioLargo Equipment Solutions & Technologies

BioLargo Equipment Solutions & Technologies, Inc. sells and distributes sustainable, best-in-class water treatment systems that solve some of the toughest challenges in the modern water industry. From PFAS capture and destruction to water reuse technologies, every system delivers on a promise of uncompromising technical performance, sustainable energy usage and waste generation metrics, and clear ROI for operations that use them. Its website is www.bestPFAStreatment.com. BioLargo Equipment Solutions & Technologies, Inc. is a wholly owned subsidiary of BioLargo, Inc., a cleantech innovator and environmental engineering solutions provider dedicated to make life better through technological innovation.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com. 

Contact Information

Dennis P. Calvert 

President and CEO, BioLargo, Inc. 

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Monday 12 February 2024

BioLargo Recruits Sally Gutierrez, Former EPA Senior Advisor, for the Board of its Water Equipment and PFAS Solutions Company

Sally Gutierrez
Westminster, CA – February 12, 2024 – BioLargo, Inc. (OTCQB:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that retired career senior executive at the US Environmental Protection Agency Sally Gutierrez has joined the board of directors of its subsidiary BioLargo Equipment Solutions & Technologies, Inc. Ms. Gutierrez will bring over thirty years of experience developing water regulations at the state and federal level to the BioLargo team to assist the company in its efforts to commercialize its innovative water treatment technologies for emerging contaminants such as per- and polyfluoroalkyl substances (PFAS).

Ms. Gutierrez has been a career senior executive for the EPA for over twenty years. She has held key positions within the EPA, primarily within its Office of Research and Development (ORD). She has held the title of Director for numerous offices within the EPA’s ORD, including the Environmental Technology Innovation Cluster Development and Support Program, the National Risk Management Research Laboratory (NRMRL), and the NRMRL Water Supply and Water Resources Division. She also served as a Senior Water Advisor for the ORD Center for Environmental Solutions and Emergency Response and the Acting Director of the Water Permits Division within the EPA’s Office of Wastewater Management in Washington, DC. 

In joining the board of BioLargo Equipment Solutions & Technologies, Ms. Gutierrez will assist the company in achieving expanded adoption of its innovative technologies in the water industry by helping navigate the rapidly changing regulatory environment surrounding newer issues in water treatment such as PFAS contamination. 

Ms. Gutierrez was drawn to join the company’s board specifically because of the significant potential for its innovative PFAS treatment solutions to safeguard American drinking water and remediate badly contaminated water around the country, an issue she says is deeply important to her.  “Of all the environmental challenges I have tackled in my career, PFAS contamination is one of the most serious public health issues,” Ms. Gutierrez commented. “BioLargo’s AEC technology stands apart as a solution that offers an effective alternative to more traditional technologies for management of PFAS especially in regard to waste generation.”

“My goal is to help BioLargo bring its PFAS treatment solution to communities across the country and make sure that every American city and town has access to safe drinking water,” said Ms. Gutierrez.

Read more about BioLargo’s PFAS treatment solutions at www.bestpfastreatment.com. 

About BioLargo Equipment Solutions & Technologies

BioLargo Equipment Solutions & Technologies, Inc. sells and distributes sustainable, best-in-class water treatment systems that solve some of the toughest challenges in the modern water industry. From PFAS capture and destruction to water reuse technologies, every system delivers on a promise of uncompromising technical performance, sustainable energy usage and waste generation metrics, and clear ROI for operations that use them. BioLargo Equipment Solutions & Technologies, Inc. is a wholly owned subsidiary of BioLargo, Inc., a cleantech innovator and environmental engineering solutions provider dedicated to make life better through technological innovation.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.  

Contact Information

Dennis P. Calvert 

President and CEO, BioLargo, Inc. 

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.


Monday 5 February 2024

Jeffrey Kightlinger, Recognized Water Industry Leader, Joins Board of BioLargo’s Water Equipment and PFAS Solutions Company

Jeffrey Kightlinger
Westminster, CA – February 5, 2024 – BioLargo, Inc. (OTCQB:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that Jeffrey Kightlinger, former CEO of the Metropolitan Water District of Southern California, has joined the board of directors of its water equipment and PFAS solutions company BioLargo Equipment Solutions & Technologies. Recently announced, the subsidiary was launched to facilitate the sales, marketing, and distribution of BioLargo’s innovative water treatment technologies, such as its effective, low-waste PFAS treatment system.

Mr. Kightlinger is renowned for his distinguished service as the longest-serving CEO of the Metropolitan Water District of Southern California, the nation’s largest municipal water provider serving over 19 million Californians. During his tenure, Mr. Kightlinger oversaw a $1.8 billion budget, and was responsible for delivery of reliable, safe water to over 300 cities, including the counties of Los Angeles, Orange, Riverside, San Bernadino, San Diego, and Ventura. He was integral in establishing some of MWDSC’s world-renowned water technology innovation programs. Mr. Kightlinger is a recognized subject matter expert on the topics of water conservation, quality, and stewardship, and is often interviewed by major water industry publications and magazines.

Mr. Kightlinger will contribute his decades-long experience in municipal water management to support BioLargo Equipment Solutions & Technologies by connecting the company with other leaders in the nation’s water industry, and by advising the company in its efforts to secure larger and more high-profile municipal water treatment projects for its proprietary treatment technologies.

He agreed to join the company’s board in part because of recent news surrounding BioLargo’s innovative, effective, and sustainable water treatment solution for drinking water contamination by per- and polyfluoroalkyl substances (PFAS), commonly known as "forever chemicals”. BioLargo recently secured a contract to install its PFAS removal technology at a drinking water system in New Jersey and intends to secure additional drinking water treatment projects in the coming year.

Mr. Kightlinger commented, “I am honored to join the board of BioLargo Equipment Solutions & Technologies, and hope that my experience in municipal water management can propel its innovative products such as its PFAS removal system the AEC.”

Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, said, “Our water treatment solutions are unique and remarkable in their technical claims and performance, and it is critical to have the right leaders on board to help guide the company to make the greatest impact in the water industry. We’re honored to have Jeffrey join our board, as his past accomplishments in the water industry have been hugely impactful in California.”

About BioLargo Equipment Solutions & Technologies

BioLargo Equipment Solutions & Technologies, Inc. sells and distributes sustainable, best-in-class water treatment systems that solve some of the toughest challenges in the modern water industry. From PFAS capture and destruction to water reuse technologies, every system delivers on a promise of uncompromising technical performance, sustainable energy usage and waste generation metrics, and clear ROI for operations that use them. BioLargo Equipment Solutions & Technologies, Inc. is a wholly owned subsidiary of BioLargo, Inc., a cleantech innovator and environmental engineering solutions provider dedicated to make life better through technological innovation.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com. 

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.